Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Trends in Biotechnology|March 27, 2016
Genome Editing of Structural Variations: Modeling and Gene CorrectionChul-Yong Park, Jin Jea Sung, Dong-Wook KimBiochemical and Biophysical Research Communications|December 9, 2008
Zebrafish Jak2a plays a crucial role in definitive hematopoiesis and blood vessel formationJin Jea Sung, Jinseon Jeon, Jong Joo Lee, et al.Human Genetics|July 1, 2016
Genome-editing technologies for gene correction of hemophiliaChul-Yong Park, Dongjin R Lee, Jin Jea Sung, et al.Stem Cell Reports|May 21, 2019
Universal Correction of Blood Coagulation Factor VIII in Patient-Derived Induced Pluripotent Stem Cells Using CRISPR/Cas9Chul-Yong Park, Jin Jea Sung, Sung-Rae Cho, et al.Experimental & Molecular Medicine|April 19, 2019
Restoration of FVIII expression by targeted gene insertion in the FVIII locus in hemophilia A patient-derived iPSCsJin Jea Sung, Chul-Yong Park, Joong Woo Leem, et al.Stem Cell Research|August 18, 2020
Generation of a gene edited hemophilia A patient-derived iPSC cell line, YCMi001-B-1, by targeted insertion of coagulation factor FVIII using CRISPR/Cas9Jin Jea Sung, Sanghyun Park, Sang-Hwi Choi, et al.Nature Protocols|October 7, 2016
Modeling and correction of structural variations in patient-derived iPSCs using CRISPR/Cas9Chul-Yong Park, Jin Jea Sung, Sang-Hwi Choi, et al.Cell Reports|October 7, 2015
Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived NeuronsChul-Yong Park, Tomer Halevy, Dongjin R Lee, et al.Cell Stem Cell|July 28, 2015
Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9Chul-Yong Park, Duk Hyoung Kim, Jeong Sang Son, et al.Stem Cell Research|April 20, 2021
Generation of Brachyury-mCherry knock-in reporter human pluripotent stem cell line (SNUe003-A-2) using CRISPR/CAS9 nucleaseJuwon Jung, Sunsook Hwang, Hyewon Seol, et al.Pageof 2